Listed by the USPTO as SPENCE, JENNIFER SUZANNE
Tech Center 1600 • Art Units: 1631 1633 1634 1651
This examiner grants 67% of resolved cases
SPENCE, JENNIFER SUZANNE is assigned to tech center 1600 and art unit 1631. The record contains 133 resolved cases, with an allowance rate of 66.9% and a median of 1350 days to allowance. The limited case volume supports directional planning, while the allowance rate indicates mixed outcomes and the median timing signals a long prosecution path.
Interviews are associated with a 46.0% lift in allowance rate, making them a significant consideration for case strategy. Vertex Pharmaceuticals Incorporated, Board of Regents of the University of Texas System, and Merck Patent GmbH are the leading companies. The principal firms are NORTON ROSE FULBRIGHT US LLP, GREENBERG TRAURIG, LLP (BOS), and HAUPTMAN HAM, LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18042037 | CONSUMABLE TISSUE-LIKE STRUCTURE GENERATED WITH MUSCLE CELLS GROWN ON EDIBLE HOLLOW FIBERS | Final Rejection | Merck Patent GmbH |
| 18850219 | SINGLE-STRAND FORM POLYNUCLEOTIDE AND USE THEREOF IN GENOME EDITING | Non-Final OA | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY |
| 18249339 | AN ADHERENT CELL CULTURE METHOD FOR GENERATING TIGHT JUNCTION BETWEEN CELLS AND ITS PRODUCT APPLICATION | Final Rejection | ZHEJIANG UNIVERSITY |
| 17640281 | CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 16482420 | ENGINEERING BLOOD VESSEL CELLS FOR TRANSPLANTATION | Non-Final OA | CORNELL UNIVERSITY |
| 17354281 | METHODS AND COMPOSITIONS FOR CULTIVATING PLURIPOTENT CELL SUSPENSIONS | Final Rejection | Life Technologies Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy66.9% of resolved applications examined by Jennifer Suzanne Spence were allowed (133 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +46.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jennifer Suzanne Spence took 1,350 days on average from filing to allowance.
Jennifer Suzanne Spence examines applications in Art Unit 1631 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
